Literature DB >> 33672427

Sarcopenia and Cognitive Function: Role of Myokines in Muscle Brain Cross-Talk.

Lucia Scisciola1, Rosaria Anna Fontanella1, Vittoria Cataldo1, Giuseppe Paolisso1, Michelangela Barbieri1.   

Abstract

Sarcopenia is a geriatric syndrome characterized by the progressive degeneration of muscle mass and function, and it is associated with severe complications, which are falls, functional decline, frailty, and mortality. Sarcopenia is associated with cognitive impairment, defined as a decline in one or more cognitive domains as language, memory, reasoning, social cognition, planning, making decisions, and solving problems. Although the exact mechanism relating to sarcopenia and cognitive function has not yet been defined, several studies have shown that skeletal muscle produces and secrete molecules, called myokines, that regulate brain functions, including mood, learning, locomotor activity, and neuronal injury protection, showing the existence of muscle-brain cross-talk. Moreover, studies conducted on physical exercise supported the existence of muscle-brain cross-talk, showing how physical activity, changing myokines' circulating levels, exerts beneficial effects on the brain. The review mainly focuses on describing the role of myokines on brain function and their involvement in cognitive impairment in sarcopenia.

Entities:  

Keywords:  cognitive impairment; exerkines; myokines; sarcopenic; skeletal muscle

Year:  2021        PMID: 33672427     DOI: 10.3390/life11020173

Source DB:  PubMed          Journal:  Life (Basel)        ISSN: 2075-1729


  10 in total

1.  Segmental Bioimpedance Variables in Association With Mild Cognitive Impairment.

Authors:  Dieu Ni Thi Doan; Boncho Ku; Kahye Kim; Minho Jun; Kyu Yeong Choi; Kun Ho Lee; Jaeuk U Kim
Journal:  Front Nutr       Date:  2022-06-02

2.  Prevalence and associated factors of possible sarcopenia and sarcopenia: findings from a Chinese community-dwelling old adults cross-sectional study.

Authors:  Jiazhi Wang; Changge Liu; Lin Zhang; Ning Liu; Lei Wang; Jingqiong Wu; Yizhao Wang; Huimin Hao; Longjun Cao; Shilei Yuan; Liping Huang
Journal:  BMC Geriatr       Date:  2022-07-18       Impact factor: 4.070

3.  Sarcopenia and motoric cognitive risk syndrome: a moderated mediation model.

Authors:  Ting Zhang; Yunyun Zhang; Ziyan Lv; Jie Xiang
Journal:  BMC Geriatr       Date:  2022-02-19       Impact factor: 3.921

4.  Diabetes, sarcopenia and chronic kidney disease; the Screening for CKD among Older People across Europe (SCOPE) study.

Authors:  Francesc Formiga; Rafael Moreno-González; Andrea Corsonello; Axel Carlsson; Johan Ärnlöv; Francesco Mattace-Raso; Tomasz Kostka; Christian Weingart; Regina Roller-Wirnsberger; Lisanne Tap; Agnieszka Guligowska; Cornel Sieber; Gerhard Wirnsberger; Rada Artzi-Medvedik; Ilan Yehoshua; Cinzia Giuli; Fabrizia Lattanzio; Xavier Corbella
Journal:  BMC Geriatr       Date:  2022-03-28       Impact factor: 3.921

Review 5.  Exercise Therapy for People With Sarcopenic Obesity: Myokines and Adipokines as Effective Actors.

Authors:  Hamed Alizadeh Pahlavani
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-17       Impact factor: 5.555

Review 6.  Effects of the FNDC5/Irisin on Elderly Dementia and Cognitive Impairment.

Authors:  Jin Peng; Jinhui Wu
Journal:  Front Aging Neurosci       Date:  2022-03-31       Impact factor: 5.750

7.  Association of Low Muscle Mass With Cognitive Function During a 3-Year Follow-up Among Adults Aged 65 to 86 Years in the Canadian Longitudinal Study on Aging.

Authors:  Anne-Julie Tessier; Simon S Wing; Elham Rahme; José A Morais; Stéphanie Chevalier
Journal:  JAMA Netw Open       Date:  2022-07-01

8.  Comparison of the prevalence and associated factors of cognitive frailty between elderly and middle-young patients receiving maintenance hemodialysis.

Authors:  Guanjie Chen; Hailin Zhang; Xiaoju Du; Lixia Yin; Huipin Zhang; Qifan Zhou
Journal:  Int Urol Nephrol       Date:  2022-04-02       Impact factor: 2.266

9.  Cortical Thickness and White Matter Hyperintensity Changes Are Associated With Sarcopenia in the Cognitively Normal Older Adults.

Authors:  Hyun Jung Kim; Ju-Hye Chung; Youngmi Eun; Se-Hong Kim
Journal:  Psychiatry Investig       Date:  2022-08-24       Impact factor: 3.202

10.  Effect of Improvement in Sarcopenia on Functional and Discharge Outcomes in Stroke Rehabilitation Patients.

Authors:  Tatsuya Matsushita; Shinta Nishioka; Shiori Taguchi; Anna Yamanouchi; Yuka Okazaki; Kana Oishi; Ryusei Nakashima; Tatsuya Fujii; Yoshiharu Tokunaga; Shinya Onizuka
Journal:  Nutrients       Date:  2021-06-25       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.